Skip to main content

Table 4 Joint association between breast cancer, microcalcifications, and breast cancer risk with respect to breast cancer subtype

From: Microcalcifications, mammographic breast density, and risk of breast cancer: a cohort study

Microcalcificationa

BI-RADS breast density

BI-RADS 1

BI-RADS 2

BI-RADS 3

BI-RADS 4

P-trendb

Total population (No. of cases)

aHR (95% CI)

Total population (No. of cases)

aHR (95% CI)

Total population (No. of cases)

aHR (95% CI)

Total population (No. of cases)

aHR (95% CI)

 

Total breast cancer

Total

 No microcalcification

1 236 398 (10 548)

[Ref]

1 156 867 (15 303)

1.40 (1.37–1.44)

1 038 262 (20 338)

1.91 (1.86–1.96)

469 110 (11 602)

2.30 (2.23–2.37)

 < 0.001

 Microcalcification

1 703 (51)

3.42 (2.60–4.50)

2 821 (118)

4.50 (3.76–5.39)

3 851 (228)

5.89 (5.16–6.71)

1 803 (127)

6.65 (5.58–7.92)

 < 0.001

Premenopausal

 No microcalcification

239 116 (2 850)

[Ref]

399 866 (6 031)

1.24 (1.19–1.30)

613 791 (12 985)

1.72 (1.65–1.79)

359 150 (9 402)

2.11 (2.02–2.21)

 < 0.001

 Microcalcification

402 (22)

4.61 (3.03–7.02)

914 (35)

3.16 (2.26–4.41)

2 101 (143)

5.58 (4.72–6.60)

1 338 (99)

5.95 (4.87–7.28)

0.004

Postmenopausal

 No microcalcification

977 104 (7 520)

[Ref]

733 417 (8 945)

1.46 (1.41–1.50)

408 272 (7 032)

1.97 (1.90–2.03)

103 026 (2 008)

2.20 (2.09–2.32)

 < 0.001

 Microcalcification

1 282 (29)

2.88 (2.00–4.15)

1 874 (81)

5.16 (4.15–6.43)

1 874 (81)

5.42 (4.36–6.75)

439 (28)

7.26 (5.01–10.53)

 < 0.001

Invasive breast cancer (IBC)

Total

         

 No microcalcification

1 236 398 (9 704)

[Ref]

1 156 867 (13 870)

1.39 (1.35–1.43)

1 038 262 (18 397)

1.98 (1.84–1.95)

469 110 (10 483)

2.29 (2.22–2.36)

 < 0.001

 Microcalcification

1 703 (46)

3.36 (2.51–4.48)

2 821 (107)

4.45 (3.68–5.39)

3 851 (199)

5.67 (4.90–6.49)

1 803 (109)

6.27 (5.19–7.57)

 < 0.001

Premenopausal

 No microcalcification

239 116 (2604)

[Ref]

399 866 (5 440)

1.23 (1.17–1.29)

613 791 (11 688)

1.71 (1.64–1.79)

359 150 (8 462)

2.11 (2.01–2.21)

 < 0.001

 Microcalcification

402 (18)

4.15 (2.61–6.60)

914 (31)

3.08 (2.16–4.39)

2 101 (124)

5.36 (4.48–6.42)

1 338 (84)

5.61 (4.52–6.98)

0.007

Postmenopausal

 No microcalcification

977 104 (6 931)

[Ref]

733 417 (8 137)

1.45 (1.40–1.50)

408 272 (6 414)

1.97 (1.90–2.04)

103 026 (1 839)

2.20 (2.09–2.33)

 < 0.001

 Microcalcification

1 282 (28)

3.00 (2.07–4.36)

1 874 (74)

5.16 (4.10–6.49)

1 874 (71)

5.22 (4.13–6.59)

439 (25)

7.06 (4.77–10.46)

 < 0.001

Breast cancer in situ (DCIS)

Total

 No microcalcification

1 236 398 (2 149)

[Ref]

1 156 867 (3 538)

1.51 (1.43–1.60)

1 038 262 (4 972)

2.06 (1.95–2.17)

469 110 (2 849)

2.40 (2.25–2.55)

 < 0.001

 Microcalcification

1 703 (13)

4.25 (2.46–7.33)

2 821 (37)

6.57 (4.75–9.10)

3 851 (74)

8.42 (6.67–10.63)

1 803 (39)

8.57 (6.24–11.78)

 < 0.001

Premenopausal

 No microcalcification

239 116 (639)

[Ref]

399 866 (1 455)

1.30 (1.18–1.43)

613 791 (3 287)

1.84 (1.68–2.01)

359 150 (2 357)

2.18 (1.99–2.39)

 < 0.001

 Microcalcification

402 (8)

7.37 (3.67–14.80)

914 (13)

5.12 (2.96–8.87)

2 101 (47)

7.69 (5.71–10.34)

1 338 (32)

7.84 (5.49–11.20)

0.216

Postmenopausal

 No microcalcification

977 104 (1 480)

[Ref]

733 417 (2 012)

1.61 (1.50–1.72)

408 272 (1 609)

2.14 (1.98–2.30)

103 026 (443)

2.24 (2.00–2.60)

 < 0.001

 Microcalcification

1 282 (5)

2.52 (1.05–6.06)

1 874 (24)

7.48 (5.00–11.21)

1 874 (24)

7.65 (5.10–11.46)

439 (7)

8.30 (3.95–17.47)

 < 0.001

  1. a Cox regression models were adjusted for age at first screening, obesity status, age at menarche, parity, oral contraceptive use, smoking status, breastfeeding, drinking status, first-degree family history of breast cancer, and physical activity. The model for postmenopausal women was additionally adjusted for age at menopause, menopausal status, and hormone replacement therapy
  2. b P for trend: asymptotic test